Skip to main content
. Author manuscript; available in PMC: 2011 Mar 1.
Published in final edited form as: Point Care. 2010 Mar 1;9(1):36–46. doi: 10.1097/POC.0b013e3181d2d8cc

Table 5.

Comparison of POC HIV tests product literature. Sensitivity estimates are relative to EIA/Western Blot gold standard.

Test Number
of
specimens* 		Specimen
Type		 Sensitivity
% (95% CI)		 Specificity
% (95% CI)		 CLIA
Classification
OraQuick
ADVANCE
Rapid HIV-
1/2 Antibody
Test 		>3,700 Oral fluid 99.3
(98.4−99.7)		 99.8
(99.6−99.9)		 Waived
>1,100 Whole Blood 99.6
(98.5−99.9)		 100
(99.7−100)		 Waived
>1,400 Plasma 99.0
(98.9−99.8)		 99.9
(99.6−99.9)		 Moderate
Uni-Gold
Recombigen
HIV 		>1,000 Whole Blood 100
(99.5−100)		 99.7
(99.0−100)		 Waived
>1,000 Serum/Plasma 100
(99.5−100)		 99.8
(99.3−100)		 Moderate
Reveal G-3
Rapid HIV-1
Antibody Test 		>3,300 Serum 99.8
(99.2−100)		 99.1
(98.8−99.4)		 Moderate
>500 Plasma 99.8
(99.0−100)		 98.6
(98.4−98.8)		 Moderate
MultiSpot
HIV-1/HIV-2
Rapid Test 		Serum 100
(99.94−100)		 99.93
(99.79−100)		 Moderate
Plasma 100
(99.94−100)		 99.9
(99.77−100)		 Moderate
Clearview
HIV 1/2
STAT-PAK
or
Clearview
COMPLETE*
HIV 1/2 		>1,300 Whole Blood 99.7
(98.9−100)		 99.9
(99.6−100)		 Waived
>1,300 Serum/Plasma 99.7
(98.9−100)		 99.9
(99.6−100)		 Moderate
*

Exact number of specimens varies for sensitivity and specificity estimates; see text for details.